# FDA recall D-0506-2023

> **Preferred Pharmaceuticals, Inc.** · Class II · drug recall initiated 2023-03-27.

## Product

Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.

## Reason for recall

CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0506-2023
- **Recalling firm:** Preferred Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-03-27
- **Report date:** 2023-04-12
- **Termination date:** 2023-10-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Anaheim, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0506-2023

## Citation

> AI Analytics. FDA recall D-0506-2023. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0506-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*